###begin article-title 0
Perinatal Plasma Monocyte Chemotactic Protein-1 Concentrations in Intrauterine Growth Restriction
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 889 896 <span type="species:ncbi:9606">infants</span>
Monocyte-chemotactic-protein-1 (MCP-1) plays vital roles in immune response, angiogenesis, and pregnancy outcome. We investigated plasma MCP-1 concentrations in 40 mothers and their 20 intrauterine-growth-restricted (IUGR) and 20 appropriate-for-gestational-age (AGA) fetuses and neonates on postnatal days 1 (N1) and 4 (N4). Maternal and fetal MCP-1 concentrations were decreased ( and  = .018, resp.), whereas N1 MCP-1 concentrations were elevated in IUGR group ( = .012). In both groups, fetal MCP-1 concentrations were lower compared to N1 and N4 ones ( = .045,  = .012, resp., for AGA,  .001 in each case for IUGR). Reduced maternal and fetal MCP-1 concentrations in IUGR may reflect failure of trophoblast invasion, suggesting that down-regulation of MCP-1 may be involved in the pathogenesis of IUGR. Increased MCP-1 concentrations in IUGR neonates and higher postnatal ones in all infants may be attributed to gradual initiation of ex utero angiogenesis, which is possibly enhanced in IUGR.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Evidence is accumulating that maintenance of a normal pregnancy is dependent on a delicate interaction between the endocrine and immune systems [1]. Disturbance of this balance can result in a wide range of abnormalities including intrauterine growth restriction (IUGR) [2].
###end p 4
###begin p 5
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
Cytokines, the local effectors of the immune system, are increasingly thought to play a key role during pregnancy [1, 3]. Chemokines, a subset of cytokines, specific in their ability to attract and activate immune cells, are thought to play pivotal roles in the immune recognition, maintenance of pregnancy, and parturition [4]. In this respect, unbalanced chemokine expression may contribute to defective placentation and pregnancy failures [3].
###end p 5
###begin p 6
###xml 56 60 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 56 60 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&#946;</italic></italic>
###xml 142 143 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 159 160 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 176 177 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 203 204 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 419 420 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 422 423 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 533 535 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 537 539 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 730 731 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 979 980 976 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Monocyte chemotactic protein (MCP)-1 is a 76-amino acid beta chemokine, which is secreted by a wide range of cell types, including monocytes [5], macrophages [6], lymphocytes [7], and endothelial cells [8]. It primarily serves as a chemotactic factor that attracts and activates monocytes/macrophages into cites of inflammation, by inducing leukocyte-endothelial cell adhesion and promoting transendothelial migration [6, 9]. Recently, a number of other functions have been ascribed to MCP-1, including that of an angiogenic factor [10, 11]. Moreover, MCP-1 expression has been demonstrated in maternal gestational tissues, such as decidua and myometrium, as well as in embryonically-derived ones, including chorion and placenta [4]. MCP-1 production increases during normal pregnancy, and even more during labor, suggesting that MCP-1 may play a role, which is more important as pregnancy advances, by locally modulating the immune system at the level of peripheral leukocytes [1]. However, the perinatal expression of MCP-1 has not been, up to the present, investigated in IUGR pregnancies.
###end p 6
###begin p 7
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 468 474 <span type="species:ncbi:9606">infant</span>
In this respect, this study was based on the hypothesis that circulating concentrations of MCP-1 might differ between IUGR cases and appropriate for gestational age (AGA) controls, since the former are characterized by abnormal immune responses, leading to inappropriate cytokine secretion [12, 13], and impaired angiogenesis [14-17]. Therefore, we aimed to evaluate and compare, for the first time to our knowledge, plasma MCP-1 concentrations in IUGR and AGA mother/infant pairs at crucial perinatal time points and investigate the association of its circulating concentrations with gender, parity, mode of delivery and, adjusted birth weight (customized centiles).
###end p 7
###begin title 8
2. MATERIALS AND METHODS
###end title 8
###begin p 9
###xml 398 400 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 402 404 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 631 633 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 254 261 <span type="species:ncbi:9606">infants</span>
The Ethics Committee of our teaching hospital approved the study protocol. All included mothers provided signed informed consent before recruitment. Forty parturients giving consecutively birth, either to 20 AGA or 20 asymmetric IUGR full-term singleton infants (birth weight </= 3rd customized centile), were included in the study. The gestation-related optimal weight computer-generated program [18, 19] was used to calculate the customized centile for each pregnancy, taking into consideration significant determinants of birth weight, such as maternal height, booking weight, ethnic group, parity, gestational age, and gender [18]. Gestational age was estimated using the date of the last menstrual period and early antenatal ultrasound. Birth weight was measured with an electronic scale.
###end p 9
###begin p 10
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 358 363 <span type="species:ncbi:9606">women</span>
Nine of the 20 mothers with IUGR offspring presented with preeclampsia [20]. The remaining 11 mothers presented with pregnancy-induced hypertension and in addition, suffered from iron-deficient anemia (3 cases), gestational diabetes mellitus (2 cases), hypothyroidism (3 cases), extreme obesity (2 cases), and cardiac arrhythmias (1 case). Five of the above women were smoking >10 cigarettes/day during the whole duration of pregnancy.
###end p 10
###begin p 11
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Doppler studies were performed in the IUGR group every 10-15 days, starting from the 32nd gestational week. During each Doppler velocimetry evaluation, three consecutive measurements of the pulsatility index (PI) of the studied vessel (uterine, umbilical, cerebral arteries) were done, and the mean value was recorded. Concerning uterine and umbilical arteries [21, 22], mean PI values were progressively found to be in the upper physiological limits for the corresponding gestational age in 13 cases (ranging between the 90th and the 95th percentile) while in the remaining seven cases PI values showed increased impedance to flow, being above the 95th percentile for gestational age. Regarding middle cerebral arteries [23], Doppler studies showed resistance to be in the lower physiological limits for gestational age, indicating the initiation of blood flow redistribution process, in order to spare vital organs (brain, heart, and adrenals). Nevertheless, amniotic fluid was diminished in all IUGR cases. For the evaluation of the amniotic fluid, the largest fluid column on the vertical plane was assessed and was defined as diminished, if <2 cm. Placental weights were reduced ranging from 255 to 400 g.
###end p 11
###begin p 12
In the AGA group, mothers were healthy and were either nonsmokers or abstained from smoking during pregnancy. Placentas were normal in appearance and weight.
###end p 12
###begin p 13
###xml 325 332 323 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 53 58 <span type="species:ncbi:9606">women</span>
Tests for congenital infections were negative in all women of both groups, and their offspring had no symptoms of intrauterine infection or signs of genetic syndromes. One- and five-minute Apgar scores were in all cases and controls >/=8. All neonates were breastfed. Demographic data of participating subjects are listed in Table 1.
###end p 13
###begin p 14
Blood was collected in pyrogen-free tubes from the following: (i) the mothers during the first stage of labor, or before receiving anesthesia in cases of elective caesarean section; (ii) the umbilical cords after double clamping, reflecting fetal state; and (iii) the neonates before feeding on postpartum days 1 (N1) and 4 (N4), characterizing transition and stabilization to extrauterine life, respectively. Plasma was separated by centrifugation and was kept frozen at  until assay.
###end p 14
###begin p 15
###xml 80 85 <span type="species:ncbi:9606">Human</span>
The determination of plasma MCP-1 concentrations was performed by ELISA (MCP-1 (Human) ELISA Kit, HBT (HyCult Biotechnology b.v) UDEN, the Netherlands). The minimum detectable concentration, intra- and interassay coefficients of variation were <10 pg/mL, 6.2% and 7.7%, respectively.
###end p 15
###begin title 16
3. STATISTICAL ANALYSIS
###end title 16
###begin p 17
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
MCP-1 data were normally distributed (Kolmogorov-Smirnov test); thus, parametric tests (Anova for repeated measures, paired samples -test with Bonferroni correction for multiple comparisons) were applied in the analysis. Spearman's or Pearson's correlation coefficients, where appropriate, were used to detect any positive or negative correlations. P < .05 was considered statistically significant.
###end p 17
###begin title 18
4. RESULTS
###end title 18
###begin p 19
###xml 119 127 119 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
Determined mean (95% confidence intervals (CI)) values of circulating MCP-1 concentrations in both groups are shown in Figure 1.
###end p 19
###begin p 20
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 199 200 199 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 445 446 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Maternal and fetal MCP-1 concentrations were significantly decreased in the IUGR compared to the AGA group after adjusting for multiple comparisons (b: 167.018, 95% CI: 114.511-219.525, P < .001 and b: 216.322, 95% CI: 40.423-392.221, P = .018, resp.). On the contrary, N1 MCP-1 concentrations were significantly elevated in the IUGR compared to the AGA group after adjusting for multiple comparisons ((b: -467.934, 95% CI: -824.383-(-111.484), P = .012).
###end p 20
###begin p 21
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In the AGA group, maternal MCP-1 concentrations were significantly lower compared to fetal, N1 and N4 ones (P = .019, P = .001, and P < .001, resp.) while fetal MCP-1 concentrations were significantly lower compared to N1 and N4 ones (P = .045 and P = .012, resp.).
###end p 21
###begin p 22
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In the IUGR group, maternal MCP-1 concentrations were significantly lower compared to fetal, N1 and N4 ones (P = .003, P < .001 and P < .001, resp.) while fetal MCP-1 concentrations were significantly lower compared to N1 and N4 ones (P < .001 in each case). Finally, in each (IUGR or AGA) group, the effect of gender, mode of delivery, and parity on plasma MCP-1 concentrations was not significant.
###end p 22
###begin title 23
5. DISCUSSION
###end title 23
###begin p 24
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1064 1066 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
During gestation, inflammatory cytokines, occasionally more abundant than growth-promoting ones, lead via direct or indirect effects to IUGR [24]. In this respect, many recent studies point to altered cytokine pattern in IUGR pregnancies, documenting up- or downregulation of several cytokines in amniotic fluid, as well as maternal and fetal circulation [2, 12, 25-30]. Thus, elevated TNF-alpha and reduced interleukin (IL)-1 beta amniotic fluid concentrations [2], as well as enhanced placental TNF-alpha secretion [31], have been implicated in vasoconstriction of the feto-placental vascular bed, resulting in IUGR. Furthermore, elevated maternal TNF-alpha, IL-6 [2, 25], IL-8 [25], and macrophage colony-stimulating factor [26] concentrations have been observed in IUGR due to placental insufficiency. On the other hand, reduced placental IL-6 production has been associated with placental ischemia and failure of fetal growth in pregnancy-induced hypertension [27]. Similarly, reduced placental IL-10 expression has been involved in the pathogenesis of IUGR [32].
###end p 24
###begin p 25
###xml 412 414 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
In line with these reports, the results of the present study indicate that circulating maternal and fetal MPC-1 concentrations are significantly lower in IUGR cases compared to AGA controls. Successful placentation involves the development of a highflow uteroplacental circulation, which is established by trophoblast invasion and transformation of the maternal intramyometrial portion of the spiral arterioles [33]. Asymmetric fetal growth restriction is attributed to reduced placental blood flow with subsequent impaired fetomaternal exchange of substrates, a process probably initiated by unsuccessful transformation of uteroplacental spiral arteries [34]. In this respect, Brosens et al. showed that the expected physiological changes in pregnancy are restricted in the decidual segments of the uteroplacental arteries in all hypertensive patients with IUGR offspring [35]. This failure of placentation has been attributed to inadequate decidual cellular immunity, limiting trophoblastic invasion [34]. Thus, it has been hypothesized that placental insufficiency in IUGR could be caused by an immunological phenomenon [12].
###end p 25
###begin p 26
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 577 579 577 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
MCP-1, abundantly produced during gestation by endometrial, myometrial, placental, and trophoblast cell types [4], has been reported to play specific roles in endometrial angiogenesis, apoptosis, proliferation, and differentiation [3]. Furthermore, MCP-1 plays an essential role in maintaining pregnancy [1, 4]. Based on these facts, we speculate that MCP-1 may regulate trophoblast invasion into the placental bed and may influence placental development and function by acting via decidual and fetal macrophages, as previously stated for macrophage colony-stimulating factor [36]. Thus, the lower maternal and fetal MCP-1 concentrations in our IUGR cohort may indicate failure of trophoblast invasion, suggesting that downregulation of MCP-1 may be involved in the pathogenesis of IUGR.
###end p 26
###begin p 27
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 344 349 <span type="species:ncbi:9606">women</span>
###xml 663 668 <span type="species:ncbi:9606">women</span>
Controversial data exist in the literature, regarding circulating MCP-1 concentrations in preeclampsia. Thus, a recent study demonstrated significantly elevated MCP-1 concentrations in preeclamptic patients [37], whereas other researchers found no significant differences in plasma MCP-1 concentrations between preeclamptic and normal pregnant women [38]. In the former study [37], it has been hypothesized that, in preeclampsia, the damaged endothelial cells and/or infiltrated macrophages may produce MPC-1, which probably promotes extension of the lesions. A possible explanation for our contradictory finding may relate to the fact that more than half of the women with IUGR offspring in our study presented with pregnancy-induced hypertension, which is not associated with endothelial dysfunction [39] and thus, with probably higher MCP-1 production.
###end p 27
###begin p 28
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 848 849 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 187 194 <span type="species:ncbi:9606">infants</span>
On the other hand, our study demonstrated increased circulating MCP-1 concentrations in IUGR neonates compared to AGA controls, as well as higher postnatal concentrations in all included infants. MCP-1 has been reported to directly promote angiogenesis, as a consequence of leukocyte infiltration, or growth factor expression [40]. Therefore, above findings may be attributed to a gradual initiation of ex utero angiogenesis, a prerequisite for tissue growth and development [41], which is possibly enhanced in IUGR cases, due to a potential initiation of the catch-up growth process [42]. In addition, the reported higher fetal MCP-1 concentrations compared to respective maternal ones may be attributed to the fact that, in late gestation, MCP-1 is predominantly released by embryonically derived tissues, including the chorion and the placenta [4].
###end p 28
###begin p 29
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
Finally, gender, parity, and the mode of delivery did not prove to have a significant effect on circulating MCP-1 concentrations in this study. Relatively, a recent report documented significantly higher MCP-1 concentrations in the placentas of primigravidas [24]. Furthermore, amniotic fluid concentrations of MCP-1 reportedly increase during spontaneous labour, suggesting its potential role in this process [43].
###end p 29
###begin p 30
###xml 351 358 <span type="species:ncbi:9606">infants</span>
In conclusion, the reduced maternal and fetal MCP-1 concentrations in our IUGR cohort may reflect failure of trophoblast invasion, suggesting that downregulation of MCP-1 may be involved in the pathogenesis of IUGR. On the other hand, the increased MCP-1 concentrations in IUGR neonates, as well as the higher postnatal concentrations in all included infants may be attributed to a gradual initiation of ex utero angiogenesis, which is possibly enhanced in IUGR cases. Additional studies are required to elucidate the physiological role of this chemokine in both normal and complicated pregnancies.
###end p 30
###begin article-title 31
###xml 98 103 <span type="species:ncbi:9606">women</span>
Differential secretion of chemokines from peripheral blood in pregnant compared with non-pregnant women
###end article-title 31
###begin article-title 32
Cytokine production and visualized effects in the feto-maternal unit: quantitative and topographic data on cytokines during intrauterine disease
###end article-title 32
###begin article-title 33
Uterine chemokines in reproductive physiology and pathology
###end article-title 33
###begin article-title 34
###xml 22 27 <span type="species:ncbi:9606">human</span>
Cytokine secretion by human fetal membranes, decidua and placenta at term
###end article-title 34
###begin article-title 35
###xml 44 49 <span type="species:ncbi:9606">human</span>
Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
###end article-title 35
###begin article-title 36
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury
###end article-title 36
###begin article-title 37
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
Human monocyte chemoattractant protein-1 (MCP-1). Full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE
###end article-title 37
###begin article-title 38
Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor
###end article-title 38
###begin article-title 39
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1
###end article-title 39
###begin article-title 40
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression
###end article-title 40
###begin article-title 41
Inhibition of the angiogenesis by the MCP-1 (monocyte chemoattractant protein-1) binding peptide
###end article-title 41
###begin article-title 42
Inflammatory cytokines in intrauterine growth retardation
###end article-title 42
###begin article-title 43
###xml 64 69 <span type="species:ncbi:9606">women</span>
Lymphocyte subpopulations in intrauterine growth retardation in women with or without previous pregnancies
###end article-title 43
###begin article-title 44
The relationship between transplacental  diffusion and placental expression of PIGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction
###end article-title 44
###begin article-title 45
The role of the anti-angiogenic factor endostatin in intrauterine growth restriction
###end article-title 45
###begin article-title 46
Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates
###end article-title 46
###begin article-title 47
Angiopoietin-2 in the perinatal period and the role of intrauterine growth restriction
###end article-title 47
###begin article-title 48
Customised antenatal growth charts
###end article-title 48
###begin article-title 49
An adjustable fetal weight standard
###end article-title 49
###begin article-title 50
###xml 116 121 <span type="species:ncbi:9606">women</span>
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
###end article-title 50
###begin article-title 51
Doppler study of uterine artery blood flow: comparison of findings in the first and second trimesters of pregnancy
###end article-title 51
###begin article-title 52
Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy
###end article-title 52
###begin article-title 53
Doppler and biophysical assessment in growth restricted fetuses: distribution of test results
###end article-title 53
###begin article-title 54
###xml 70 75 <span type="species:ncbi:9606">women</span>
###xml 101 122 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Cytokine profiles in peripheral, placental and cord blood in pregnant women from an area endemic for Plasmodium falciparum
###end article-title 54
###begin article-title 55
Expression pattern of cytokines in the different compartment of the feto-maternal unit under various conditions
###end article-title 55
###begin article-title 56
Elevated levels of serum macrophage colony-stimulating factor in normotensive pregnancies complicated by intrauterine fetal growth restriction
###end article-title 56
###begin article-title 57
Study on relationship between detection of interleukin-6 and its mRNA and pregnancy induced hypertension
###end article-title 57
###begin article-title 58
Cytokines in the placenta of Pakistani newborns with and without intrauterine growth retardation
###end article-title 58
###begin article-title 59
Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls
###end article-title 59
###begin article-title 60
Umbilical cord plasma interleukin-6 and fetal growth restriction in preeclampsia: a prospective study in Norway
###end article-title 60
###begin article-title 61
###xml 60 65 <span type="species:ncbi:9606">human</span>
Increased production of tumor necrosis factor- TNF- by IUGR human placentae
###end article-title 61
###begin article-title 62
Aberrations in placental cytokine mRNA related to intrauterine growth retardation
###end article-title 62
###begin article-title 63
###xml 31 36 <span type="species:ncbi:9606">human</span>
Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia
###end article-title 63
###begin article-title 64
###xml 131 138 <span type="species:ncbi:9606">infants</span>
Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants
###end article-title 64
###begin article-title 65
Fetal growth retardation and the arteries of the placental bed
###end article-title 65
###begin article-title 66
###xml 87 92 <span type="species:ncbi:9606">human</span>
Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface
###end article-title 66
###begin article-title 67
Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells
###end article-title 67
###begin article-title 68
###xml 30 35 <span type="species:ncbi:9606">women</span>
Cytokine mapping of sera from women with preeclampsia and normal pregnancies
###end article-title 68
###begin article-title 69
Maternal central hemodynamics in hypertensive disorders of pregnancy
###end article-title 69
###begin article-title 70
Analysis of the role of chemokines in angiogenesis
###end article-title 70
###begin article-title 71
The codependence of angiogenesis and chronic inflammation
###end article-title 71
###begin article-title 72
Fetal growth restriction: relation to growth and obesity at the age of 9 years
###end article-title 72
###begin article-title 73
###xml 69 74 <span type="species:ncbi:9606">women</span>
Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection
###end article-title 73
###begin p 74
MCP-1 concentrations in the plasma of mothers (MS), fetuses (UC), and neonates on day 1 (N1) and 4 (N4) postpartum in appropriate for gestational age (AGA) and intrauterine growth restricted (IUGR) groups. Bars represent the mean values and error bars one SD of the mean.
###end p 74
###begin p 75
Demographic data for AGA and IUGR neonates and their mothers.
###end p 75

